AnalystsYun ZhongYun Zhong's Stock Forecasts
AnalystsYun Zhong
Sectors:
Industries:
Analyst Ranking
Bottom 8%
#4853 out of 5217 analysts
Average Return
-5.22%
Win Rate
43%22 out of 51
Risk vs Reward
Poor
Good
Yun Zhong's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Camp4 Therapeutics CorpCAMP | +171.86% | $1.99 | $5.41 | 2025-05-27 - 2026-03-13 | Buy |
Opus Genetics IncIRD | +154.04% | $1.98 | $5.03 | 2025-10-29 - 2026-03-13 | Buy |
Moonlake ImmunotherapeuticsMLTX | +138.91% | $7.17 | $17.13 | 2025-09-30 - 2026-03-13 | Buy |
Protagonist Therapeutics IncPTGX | +88.95% | $48.88 | $92.36 | 2025-03-28 - 2026-03-13 | Buy |
Wave Life Sciences LtdWVE | +87.07% | $6.96 | $13.02 | 2025-06-23 - 2026-03-13 | Buy |
Yun Zhong Analyst Color
Get additional color on Yun Zhong's coverage of popular stocks
Yun Zhong's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Opus Genetics IncIRD | 2 | Buy | $10.00 | +98.81% | Maintains | 4 days ago |
Wave Life Sciences LtdWVE | 4 | Buy | $35.00 | +168.82% | Maintains | 10 days ago |
Mannkind CorpMNKD | 1 | Buy | $8.00 | +188.81% | Maintains | 11 days ago |
Ascendis Pharma AASND | 4 | Buy | $273.00 | +20.81% | Maintains | a month ago |
Sarepta Therapeutics IncSRPT | 6 | Buy | $34.00 | +107.32% | Maintains | 2 months ago |
Rezolute IncRZLT | 2 | Hold | $2.00 | -22.93% | Maintains | 2 months ago |
Keros Therapeutics IncKROS | 3 | Hold | $16.00 | +45.19% | Maintains | 4 months ago |
Protagonist Therapeutics IncPTGX | 3 | Buy | $86.00 | -6.89% | Maintains | 5 months ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $18.00 | +5.08% | Maintains | 6 months ago |
Passage Bio IncPASG | 3 | Buy | $40.00 | +436.91% | Maintains | 7 months ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $28.00 | +437.43% | Initiates Coverage On | 7 months ago |
Voyager Therapeutics IncVYGR | 1 | Buy | $8.00 | +79.37% | Maintains | 7 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Buy | $8.00 | +47.87% | Initiates Coverage On | 10 months ago |
Rocket Pharmaceuticals IncRCKT | 2 | Buy | $32.00 | +576.53% | Reiterates | 10 months ago |
Anavex Life Sciences CorpAVXL | 2 | Strong Buy | $28.00 | N/A | Maintains | 3 years ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Tectonic Therapeutic IncTECX | 2 | Strong Buy | $48.00 | N/A | Upgrades | 3 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Renovacor IncRCOR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Strong Buy | $75.00 | N/A | Maintains | 4 years ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 4 years ago |
Bluebird Bio IncBLUE | 2 | Hold | $700.00 | N/A | Downgrades | 5 years ago |
Uniqure NvQURE | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 5 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Sio Gene Therapies IncSIOX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 5 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 5 years ago |
Mereo Biopharma Group PLCMREO | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Nightstar Therapeutics PLCNITE1 | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.